BiotechTube
Home/Revel Pharmaceuticals/Vincent Monnier, MD
VM

Vincent Monnier, MD

Scientific Advisor

Revel Pharmaceuticals

Therapeutic Areas

AgingChronic IllnessAutoimmunity

Revel Pharmaceuticals Pipeline

DrugIndicationPhase
Toxic Metabolite Clearance PlatformAge-related diseases (e.g., diabetic complications, neurodegeneration)Preclinical

Leadership Team at Revel Pharmaceuticals

AC
Aaron Cravens, PhD
Co-Founder & CEO
JC
Jason Crawford, PhD
Co-Founder & Scientific Advisor
RH
Ram H. Nagaraj, PhD
Scientific Advisor
KI
Kenneth I. Moch, MBA
Scientific & Business Advisor
View full Revel Pharmaceuticals profile